The DOI matches its Crossref record.
Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection
Abstract
Background: The debate regarding the optimal drainage method for acute obstructive upper urinary tract infection persists, focusing on the choice between percutaneous nephrostomy (PCN) and retrograde ureteral stenting (RUS). Aims: This study aims to systematically examine the perioperative outcomes and safety associated with PCN and RUS in treating acute obstructive upper urinary tract infections. Methods: A comprehensive investigation was conducted using the Medline, Embase, Web of Science, and Cochrane databases up to December 2022, following the guidelines of the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) statement. The utilized keywords included ‘PCN’, ‘RUS’, ‘acute upper obstructive uropathy’, and ‘RCT’. Inclusion criteria encompassed studies providing accurate and analyzable data, which incorporated the total subject count, perioperative outcomes, and complication rates. The assessed perioperative outcomes included fluoroscopy time, normalization of temperature, normalization of serum creatinine, normalization of white blood cell (WBC) count, and operative time. Safety outcomes encompassed failure rate, intraoperative and postoperative hematuria, postoperative fever, postoperative pain, and postoperative nephrostomy tube or stent slippage rate. The study protocol was prospectively registered at PROSPERO (CRD42022352474). Results: The meta-analysis encompassed 7 trials involving 727 patients, with 412 assigned to the PCN group and 315 to the RUS group. The outcome of the meta-analysis unveiled a reduced occurrence of postoperative hematuria in the PCN group [odds ratio (OR) = 0.54, 95% confidence interval (CI) 0.30–0.99, p = 0.04], along with a decreased frequency of insertion failure (OR = 0.42, 95% CI 0.21–0.81, p = 0.01). In addition, the RUS group exhibited a shorter fluoroscopy time than the PCN group (mean difference = 0.31, 95% CI 0.14–0.48, p = 0.0004). Conclusion: Given the significant impact of hematuria and catheterization failure on postoperative quality of life, the preference for PCN appears more advantageous than RUS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“meta-analytic signals indicate that patient-level and anatomic factors (e.g., stone size/burden and hydronephrosis grade) shape recovery trajectories and re-intervention risks more than the initial drainage route per se [7]”
From Time to Decompression in Obstructive Urosepsis from Ureteral Calculi: Thresholds, Initial Diversion, and Early Biomarkers: A Systematic Review (2025) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 35
- 10.1016/j.cger.2009.06.003 · DOI
- 10.2215/CJN.15341121 · DOI
- 10.1111/apa.14482 · DOI
- 10.1016/j.cnur.2018.07.007 · DOI
- 10.1016/j.juro.2014.07.005 · doi:10.1016/j.juro.2014.07.005
- 10.1016/j.jpurol.2021.09.001 · doi:10.1016/j.jpurol.2021.09.001
- 10.1097/MOU.0000000000000364 · DOI
- 10.21037/tau.2017.10.08 · doi:10.21037/tau.2017.10.08
- 10.1016/j.jiac.2018.08.002 · doi:10.1016/j.jiac.2018.08.002
- 10.1016/j.ajem.2015.12.068 · DOI
- 10.1097/MD.0000000000018519 · DOI
- 10.3389/fsurg.2021.718583 · DOI
- 10.1016/j.urology.2004.06.029 · doi:10.1016/j.urology.2004.06.029
- 10.1007/s00330-005-0136-7 · doi:10.1007/s00330-005-0136-7
- 10.1111/iju.14331 · doi:10.1111/iju.14331
- 10.1111/bju.12768 · doi:10.1111/bju.12768
- 10.1016/S0022-5347(01)62511-4 · DOI · Paper page
- 10.14260/jemds/2015/455 · doi:10.14260/jemds/2015/455
- 10.1016/j.jiac.2020.11.022 · DOI · Paper page
- 10.12669/pjms.293.3563 · doi:10.12669/pjms.293.3563
- 10.1016/S0022-5347(05)66434-8 · DOI · Paper page
- 10.1016/j.mcna.2017.10.013 · doi:10.1016/j.mcna.2017.10.013
- 10.1016/j.juro.2012.09.088 · DOI · Paper page
- 10.1016/S0022-5347(17)40763-4 · doi:10.1016/s0022-5347(17)40763-4
- 10.1016/j.jvir.2015.11.045 · DOI
- 10.1111/bju.12918 · doi:10.1111/bju.12918
- 10.1186/s12894-019-0510-4 · DOI · Paper page
- 10.4111/icu.2018.59.6.371 · doi:10.4111/icu.2018.59.6.371
- 10.1089/end.2020.0867 · doi:10.1089/end.2020.0867
- 10.1111/bju.12161 · DOI · Paper page
- 10.1038/s41598-021-86136-y · DOI · Paper page
- 10.5527/wjn.v5.i2.172 · doi:10.5527/wjn.v5.i2.172
- 10.1016/j.euf.2018.09.001 · doi:10.1016/j.euf.2018.09.001
- 10.1007/s00240-018-1078-2 · doi:10.1007/s00240-018-1078-2
- 10.1016/S1051-0443(94)71470-6 · doi:10.1016/s1051-0443(94)71470-6
Cited by
Benea, A., Porav-Hodade, D., Turaiche, M., Rosca, O., Lighezan, D.-F., Rachieru, C., Stanga, L., Ilie, A. C., Sarau, O. S., & Sarau, C. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238546 · Cited by 5
Metadata
- Authors
- Wang, X., Wu, G., Wang, T., Liu, S., Ding, G., Mao, Q., Chu, Y., Cui, Y., & Wu, J.
- Affiliations
- Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China
- Department of Scientific Research, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China
- Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China
- Department of Urology, Yantai Yuhuangding Hospital, Qingdao University, No. 20 East Yuhuangding Road, Yantai, Shandong 264000, China
- ORCID
- Wang, Xidong
- Venue
- Therapeutic Advances in Urology
- Publisher
- SAGE Publications
- Published
- 2024-01
- Volume
- 16
- ISSN
- 1756-2872
- 1756-2880
- Cited by
- 6
- References
- 0
- Language
- en
- Funders
- Jitao Wu (National Natural Science Foundation of China, Taishan Scholars Program of Shandong Province)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection. https://app.cochat.ai/papers/10.1177/17562872241241854
- The paper
- Wang, X., Wu, G., Wang, T., Liu, S., Ding, G., Mao, Q., Chu, Y., Cui, Y., & Wu, J. (2024). Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection. Therapeutic Advances in Urology. https://doi.org/10.1177/17562872241241854
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.